Low-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three cases

dc.contributor.authorUguz, Faruk
dc.date.accessioned2024-02-23T14:34:38Z
dc.date.available2024-02-23T14:34:38Z
dc.date.issued2013
dc.departmentNEÜen_US
dc.description.abstractData on the use of a combination of antidepressants during pregnancy are inadequate. This report presents the beneficial effect of low-dose mirtazapine added onto selective serotonin reuptake inhibitors in the treatment of the symptoms of severe nausea, insomnia and loss of appetite accompanying psychiatric disorders during pregnancy, which is an important problem in clinical practice. The psychiatric diagnoses were determined with the Structured Clinical Interview for the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Assessments were performed with the Clinical Global Impression-Improvement Scale and the 17-item Hamilton Rating Scale for Depression. Further studies should be carried out to confirm the positive effects and safety of an additional low-dose mirtazapine in these cases.en_US
dc.identifier.doi10.3109/14767058.2013.766697
dc.identifier.endpage1068en_US
dc.identifier.issn1476-7058
dc.identifier.issn1476-4954
dc.identifier.issue11en_US
dc.identifier.pmid23363390en_US
dc.identifier.scopus2-s2.0-84879408799en_US
dc.identifier.scopusqualityQ2en_US
dc.identifier.startpage1066en_US
dc.identifier.urihttps://doi.org/10.3109/14767058.2013.766697
dc.identifier.urihttps://hdl.handle.net/20.500.12452/15685
dc.identifier.volume26en_US
dc.identifier.wosWOS:000320816800003en_US
dc.identifier.wosqualityQ4en_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherTaylor & Francis Ltden_US
dc.relation.ispartofJournal Of Maternal-Fetal & Neonatal Medicineen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/closedAccessen_US
dc.subjectAntidepressantsen_US
dc.subjectMirtazapineen_US
dc.subjectPregnancyen_US
dc.titleLow-dose mirtazapine added to selective serotonin reuptake inhibitors in pregnant women with major depression or panic disorder including symptoms of severe nausea, insomnia and decreased appetite: three casesen_US
dc.typeArticleen_US

Dosyalar